top of page

SS‑31 (Elamipretide)

$120.00Price

Recommended Dosage

  • Common wellness/research protocol: 5–10 mg subcutaneously once daily, often for cycles of 2–8 weeks depending on goals. Start at 5 mg daily for the first 1–2 weeks to assess response, then titrate to 10 mg if needed.

  • Other reported ranges: 2 mg daily for short acute support (2–4 days or weeks); up to 10–20 mg daily in some advanced protocols under supervision. Some users follow 5 days on/2 days off or longer cycles (e.g., 8–12 weeks) with breaks. Subcutaneous injection is the standard reported route.

  • Reconstitution example (for a typical 10 mg vial): Add 1 mL bacteriostatic water (yielding 10 mg/mL). Use an insulin syringe: 5 mg ≈ 0.5 mL (50 units on U-100); 10 mg ≈ 1 mL (100 units). Inject on an empty stomach, often in the morning or evening.

Dosing is highly individualized based on goals (e.g., energy, recovery, anti-aging), age, body weight, and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.

Let me know if you'd like the next peptide formatted the same way!

  • Key Potential Benefits of SS-31 (Elamipretide)

    1. Targeted Mitochondrial Protection and Stabilization

      • Selectively binds to cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure and optimizing electron transport chain organization into supercomplexes.

      • Prevents cardiolipin peroxidation and maintains cytochrome c in its electron-carrying form rather than peroxidase activity, preserving mitochondrial integrity under stress.

      • Improves overall mitochondrial membrane potential and reduces electron leakage without affecting healthy mitochondria.

    2. Enhanced Cellular Energy Production (ATP Synthesis)

      • Boosts oxidative phosphorylation efficiency, increasing ATP output and restoring energy deficits in aged or stressed cells.

      • Rapidly reverses age-related declines in mitochondrial energetics, improving coupling of oxidative phosphorylation and cellular energy state.

      • Supports higher energy availability for high-demand tissues such as muscle, heart, brain, and kidneys.

    3. Reduction of Oxidative Stress and ROS

      • Scavenges mitochondrial reactive oxygen species (ROS) and restores redox homeostasis, shifting the proteome toward a more youthful, reduced state.

      • Lowers protein oxidation, S-glutathionylation, and other oxidative modifications linked to aging and cellular damage.

      • Inhibits opening of the mitochondrial permeability transition pore, preventing swelling and apoptosis under stress.

    4. Improved Muscle Function and Exercise Tolerance

      • Enhances skeletal muscle mitochondrial function, reversing age-related energetic deficits and increasing exercise capacity and resistance to fatigue.

      • Supports muscle force production, endurance, and recovery by optimizing ADP sensitivity and mitochondrial quality.

      • Helps counteract sarcopenia and improves physical performance in aging models.

    5. Cardiovascular and Organ Protection

      • Improves heart function, including diastolic relaxation and systolic performance, while reducing fibrosis and oxidative damage in cardiac tissue.

      • Protects kidney, brain, and other organs from mitochondrial dysfunction, inflammation, and stress-induced injury.

      • Promotes better metabolic health, neurovascular coupling, and overall physiological resilience in aged or diseased states.

    6. Anti-Aging and Regenerative Support

      • Reverses multiple hallmarks of mitochondrial aging, including redox imbalance and reduced bioenergetics, supporting broader healthspan markers.

      • Contributes to improved cognitive function, synaptic health, and reduced inflammation in brain aging models.

      • Enhances tissue repair, vitality, and cellular homeostasis as part of comprehensive mitochondrial rejuvenation strategies.

    These benefits are primarily drawn from preclinical animal studies and mechanistic research showing SS-31's selective action on dysfunctional mitochondria.

bottom of page